These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Endothelium-dependent relaxation resistant to N omega-nitro-L-arginine in the rat hepatic artery and aorta.
    Author: Zygmunt PM, Grundemar L, Högestätt ED.
    Journal: Acta Physiol Scand; 1994 Sep; 152(1):107-14. PubMed ID: 7810328.
    Abstract:
    Nitric oxide (NO)-independent pathways contributing to acetylcholine (ACh)-induced relaxation were examined in the rat isolated hepatic artery and aorta at low and high levels of precontraction induced by phenylephrine (PhE). In the hepatic artery, the ACh-induced relaxation was unaffected by the NO synthase inhibitors N omega-nitro-L-arginine (L-NOARG, 0.3 mM) and N omega-nitro-L-arginine methyl ester (0.1 mM) at either level of pre-contraction. In the aorta, L-NOARG virtually abolished the ACh-induced relaxation at a high level, but only partially reduced the response at a low level of precontraction. Methylene blue (10 microM) and indomethacin (10 microM) did not affect the ACh-induced relaxation in the hepatic artery. L-NOARG completely inhibited the cGMP and cAMP increases induced by ACh in both types of artery. In the presence of L-NOARG, ACh was unable to relax the hepatic artery precontracted by K+. The sensitivity to PhE was increased less by L-NOARG (threefold) than after endothelial denudation (tenfold) in the hepatic artery, whereas no such difference was observed in the aorta. The relaxation induced by the NO donor 3-morpholino-sydnonimin did not differ between the arteries after endothelial denudation. These results are compatible with the existence of an endothelium-dependent inhibitory pathway distinct from the NO and cyclooxygenase pathways. This pathway seems to contribute more to the ACh-induced relaxation in the hepatic artery than in the aorta, whereas the opposite appears to be true for the NO pathway.
    [Abstract] [Full Text] [Related] [New Search]